Swedish drugmaker SOBI soars on $8 billion takeover bid from U.S. private equity

Swedish drugmaker SOBI soars on $8 billion takeover bid from U.S. private equity

By Christy Gren - Sep 03, 2021

Swedish drugmaker Orphan Biovitrum (SOBI) has agreed to an $8 billion takeover bid from US private equity firm Advent International Singapore’s sovereign wealth fund GIC.

Read More